These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38634664)

  • 21. Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3.
    Scholten DJ; Wijtmans M; van Senten JR; Custers H; Stunnenberg A; de Esch IJ; Smit MJ; Leurs R
    Mol Pharmacol; 2015 Apr; 87(4):639-48. PubMed ID: 25576486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric modulators targeting CNS muscarinic receptors.
    Bock A; Schrage R; Mohr K
    Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological modulation of chemokine receptor function.
    Scholten DJ; Canals M; Maussang D; Roumen L; Smit MJ; Wijtmans M; de Graaf C; Vischer HF; Leurs R
    Br J Pharmacol; 2012 Mar; 165(6):1617-1643. PubMed ID: 21699506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Advances in Allosteric Modulation of Muscarinic Receptors.
    Jakubik J; El-Fakahany EE
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32085536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational potential of allosteric modulators targeting the cannabinoid CB
    Lu D; Immadi SS; Wu Z; Kendall DA
    Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators.
    Farmer JP; Mistry SN; Laughton CA; Holliday ND
    FASEB J; 2022 Nov; 36(11):e22576. PubMed ID: 36183332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2.
    Casella BM; Farmer JP; Nesheva DN; Williams HEL; Charlton SJ; Holliday ND; Laughton CA; Mistry SN
    J Med Chem; 2023 Sep; 66(18):12911-12930. PubMed ID: 37523859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology.
    Muraleetharan A; Wang Y; Rowe MC; Gould A; Gregory KJ; Hellyer SD
    Mol Pharmacol; 2023 Jun; 103(6):325-338. PubMed ID: 36921922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of receptor allosterism.
    Gregory KJ; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2010 Dec; Chapter 1():Unit 1.21. PubMed ID: 21935895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanisms of Biased and Probe-Dependent Signaling at CXC-Motif Chemokine Receptor CXCR3 Induced by Negative Allosteric Modulators.
    Brox R; Milanos L; Saleh N; Baumeister P; Buschauer A; Hofmann D; Heinrich MR; Clark T; Tschammer N
    Mol Pharmacol; 2018 Apr; 93(4):309-322. PubMed ID: 29343553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and application of the first radioligand targeting the allosteric binding pocket of chemokine receptor CXCR3.
    Bernat V; Heinrich MR; Baumeister P; Buschauer A; Tschammer N
    ChemMedChem; 2012 Aug; 7(8):1481-9. PubMed ID: 22689503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
    Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
    J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
    Keov P; Sexton PM; Christopoulos A
    Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The operational model of allosteric modulation of pharmacological agonism.
    Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
    Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.